{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:40:37Z","timestamp":1779910837260,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00120-016-0040-6","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T07:11:53Z","timestamp":1456211513000},"page":"401-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Einfluss von Medikamenten auf urologische Krankheiten","Influence of drugs on urological diseases"],"prefix":"10.1007","volume":"55","author":[{"given":"P. A.","family":"Th\u00fcrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s00103-013-1667-8","volume":"56","author":"H Knopf","year":"2013","unstructured":"Knopf H, Grams G (2013) Arzneimittelanwendung von Erwachsenen in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl 56:868\u2013877","journal-title":"Bundesgesundheitsbl"},{"issue":"10","key":"40_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s15006-014-2871-7","volume":"156","author":"PA Th\u00fcrmann","year":"2014","unstructured":"Th\u00fcrmann PA (2014) Polypharmazie. Treiben Sie den Teufel nicht mit dem Beelzebub aus! MMW Fortschr Med 156(10):56\u201361","journal-title":"MMW Fortschr Med"},{"issue":"35-36","key":"40_CR3","first-page":"A-1410","volume":"112","author":"HE Kr\u00fcger-Brand","year":"2015","unstructured":"Kr\u00fcger-Brand HE (2015) Arzneimitteltherapie: Medikationsplan f\u00fcr mehr Sicherheit. Dtsch Arztebl 112(35-36):A-1410\u2013A-1414","journal-title":"Dtsch Arztebl"},{"key":"40_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/978-3-642-44942-0_45","volume-title":"Facharztwissen Urologie","author":"B Wefer","year":"2014","unstructured":"Wefer B, Loch A (2014) Harninkontinenz im Erwachsenenalter. In: Schmelz H\u2011U, Sparwasser C, Weidner W (Hrsg) Facharztwissen Urologie. Springer, Berlin, S\u00a0467\u2013485"},{"key":"40_CR5","first-page":"111","volume-title":"Urologie","author":"K Gust","year":"2014","unstructured":"Gust K, Bartsch G, Haferkamp A (2014) Funktionsst\u00f6rungen des unteren Harntraktes. In: Hautmann R, Gschwend JE (Hrsg) Urologie. Springer, Berlin, S 111\u2013130"},{"issue":"7","key":"40_CR6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/00002512-200825070-00001","volume":"25","author":"P Tsakiris","year":"2008","unstructured":"Tsakiris P, Oelke M, Michel MC (2008) Drug-induced urinary incontinence. Drugs Aging 25(7):541\u2013549","journal-title":"Drugs Aging"},{"key":"40_CR7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00120-003-0455-8","volume":"42","author":"T Schneider","year":"2003","unstructured":"Schneider T, R\u00fcbben H, Michel MC (2003) Die medikamenten-induzierte Dysfunktion der Harnblase. Urologe 42:1588\u20131593","journal-title":"Urologe"},{"issue":"1","key":"40_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002018-199819010-00004","volume":"19","author":"MJ Drake","year":"1998","unstructured":"Drake MJ, Nicon PM, Crew JP (1998) Drug-induced bladder and urinary disorders. Drug Saf 19(1):45\u201355","journal-title":"Drug Saf"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pds.705","volume":"11","author":"KLL Movig","year":"2002","unstructured":"Movig KLL, Leufkens HGM, Belitser SV, Lenderink AW, Egberts ACG (2002) Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf 11:271\u2013279","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"40_CR10","first-page":"25","volume":"4","author":"M Basu","year":"2009","unstructured":"Basu M, Duckett JRA (2009) Update on duloxetine for the management of stress urinary incontinence. Clin Interv Aging 4:25\u201330","journal-title":"Clin Interv Aging"},{"issue":"13","key":"40_CR11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","volume":"310","author":"JE Manson","year":"2013","unstructured":"Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE et al (2013) The women\u2019s health initiative hormone therapy trials: update and overview of health outcomes during the intervention and post-stopping phases. JAMA 310(13):1353\u20131368","journal-title":"JAMA"},{"issue":"2","key":"40_CR12","first-page":"CD001405","volume":"2003","author":"B Moehrer","year":"2003","unstructured":"Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003(2):CD001405","journal-title":"Cochrane Database Syst Rev"},{"key":"40_CR13","first-page":"CD001405","volume":"4","author":"JD Cody","year":"2009","unstructured":"Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM (2009) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 4:CD001405","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"40_CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00002018-200831050-00002","volume":"31","author":"KMC Verhamme","year":"2008","unstructured":"Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R (2008) Drug-induced urinary retention. Drug Saf 31(5):373\u2013388","journal-title":"Drug Saf"},{"issue":"19","key":"40_CR15","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","volume":"296","author":"SA Kaplan","year":"2006","unstructured":"Kaplan SA, Roehrborn CG, Rovner ES et al (2006) Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 296(19):2319\u20132328","journal-title":"JAMA"},{"key":"40_CR16","first-page":"122","volume-title":"Facharztwissen Urologie","author":"T Knoll","year":"2014","unstructured":"Knoll T (2014) Urolithiasis. In: Schmelz HU, Sparwasser C, Weidner W (Hrsg) Facharztwissen Urologie. Springer, Berlin, S 122\u2013136"},{"key":"40_CR17","first-page":"1","volume":"\u25a0","author":"A Pfau","year":"2015","unstructured":"Pfau A, Eckardt KU, Knauf F (2015) Diagnostik und Therapie der Nephrolithiasis. Internist 1\u20136. doi:10.1007\/s00108-015-3758-0","journal-title":"Internist"},{"issue":"3","key":"40_CR18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003495-200464030-00003","volume":"64","author":"M Daudon","year":"2004","unstructured":"Daudon M, Jungers P (2004) Drug-induced renal calculi. Drugs 64(3):245\u2013275","journal-title":"Drugs"},{"key":"40_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ckj\/sfu008","volume":"7","author":"H Izzedine","year":"2014","unstructured":"Izzedine H, Lescure FX, Bonnet F (2014) HIV medication-based urolithiasis. Clin Kidney J 7:121\u2013126","journal-title":"Clin Kidney J"},{"key":"40_CR20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/2193-1801-3-551","volume":"3","author":"M Regensburger","year":"2014","unstructured":"Regensburger M, Huttner HB, Doerfler A, Schwab S, Staykov D (2014) Propofol-related urine discoloration in a patient with fatal atypical intracerebral hemorrhage treated with hypothermia. Springerplus 3:551","journal-title":"Springerplus"},{"key":"40_CR21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00345-006-0136-5","volume":"24","author":"Th Stadler","year":"2006","unstructured":"Stadler Th, Bader M, \u00dcckert S, Staehler M, Becker A, Stief CG (2006) Adverse effects of drug therapies on male and female sexual function. World J Urol 24:623\u2013629","journal-title":"World J Urol"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1192\/bjp.bp.112.110650","volume":"202","author":"TS Baldwin","year":"2013","unstructured":"Baldwin TS, Foong T (2013) Antidepressant drugs and sexual dysfunction. Br J Psychiatr 202:396\u2013397","journal-title":"Br J Psychiatr"},{"key":"40_CR23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4088\/JCP.v67n0210","volume":"67","author":"M Fava","year":"2006","unstructured":"Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ (2006) Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J\u00a0Clin Psychiatry 67:240\u2013246","journal-title":"J Clin Psychiatry"},{"key":"40_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5534\/wjmh.2012.30.3.153","volume":"30","author":"YW Park","year":"2012","unstructured":"Park YW, Kim Y, Lee JH (2012) Antipsychotic-induced sexual dysfunction and its management. World J Mens Health 30:153\u2013159","journal-title":"World J Mens Health"},{"key":"40_CR25","first-page":"CD003546","volume":"11","author":"HM Schmidt","year":"2012","unstructured":"Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM (2012) Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev 11:CD003546","journal-title":"Cochrane Database Syst Rev"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00115-008-2578-z","volume":"79","author":"J Bauer","year":"2008","unstructured":"Bauer J, Klingm\u00fcller D (2008) Welches Antiepileptikum f\u00fcr den Mann? Kritische Beurteilung aktueller Kenntnisse aus epileptologischer und andrologischer Sicht. Nervenarzt 79:1407\u20131415","journal-title":"Nervenarzt"},{"key":"40_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12471-013-0471-2","volume":"21","author":"MPJ Nicolai","year":"2013","unstructured":"Nicolai MPJ, Liem SS, Both S, Pelger RCM, Putter H, Schalij MJ, Elzevier HW (2013) What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I. Neth Heart J 21:540\u2013544","journal-title":"Neth Heart J"},{"issue":"6","key":"40_CR28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00003495-200565060-00005","volume":"65","author":"R Dusing","year":"2005","unstructured":"Dusing R (2005) Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs 65(6):773\u2013786","journal-title":"Drugs"},{"issue":"2","key":"40_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/08038020310021967","volume":"2003","author":"R Dusing","year":"2003","unstructured":"Dusing R (2003) Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2003(2):29\u201334","journal-title":"Blood Press Suppl"},{"issue":"1","key":"40_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.amjhyper.2003.08.016","volume":"17","author":"R Fogari","year":"2004","unstructured":"Fogari R, Preti P, Zoppi A et al (2004) Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 17(1):77\u201381","journal-title":"Am J Hypertens"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/JCP.0b013e3181c8273d","volume":"30","author":"F Andersohn","year":"2010","unstructured":"Andersohn F, Schmedt N, Weinmann S, Willich SN, Garbe E (2010) Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol 30:68\u201371","journal-title":"J Clin Psychopharmacol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-016-0040-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0040-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:07:27Z","timestamp":1692230847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-016-0040-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s00120-016-0040-6","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}